the safety of flurbiprofen ( ansaid , upjohn ) was assessed after pooling data on kidney and liver function collected from nine separate phase iii clinical trials involving 1,677 patients ( 941 receiving flurbiprofen and 736 receiving comparison drugs ) with ankylosing spondylitis , osteoarthritis , or rheumatoid arthritis .
C0016377
flurbiprofen
C0003873
rheumatoid